111 related articles for article (PubMed ID: 2539013)
1. Morphologic and cytochemical characteristics of acute promyelocytic leukemia.
Davey FR; Davis RB; MacCallum JM; Nelson DA; Mayer RJ; Ball ED; Griffin JD; Schiffer CA; Bloomfield CD
Am J Hematol; 1989 Apr; 30(4):221-7. PubMed ID: 2539013
[TBL] [Abstract][Full Text] [Related]
2. Nonspecific esterase of acute promyelocytic leukemia (M3).
Matsuo T; Jain NC; Bennett JM
Am J Hematol; 1988 Nov; 29(3):148-51. PubMed ID: 3189310
[TBL] [Abstract][Full Text] [Related]
3. Acute promyelocytic leukemia: morphological aspects.
Castoldi GL; Liso V; Specchia G; Tomasi P
Leukemia; 1994 Sep; 8(9):1441-6. PubMed ID: 8090023
[TBL] [Abstract][Full Text] [Related]
4. Cytochemical and immunophenotypic heterogeneity in acute promyelocytic leukemia.
Das Gupta A; Sapre RS; Shah AS; Advani SH; Nair CN
Acta Haematol; 1989; 81(1):5-9. PubMed ID: 2467498
[TBL] [Abstract][Full Text] [Related]
5. Short-term treatment for adult hypergranular and microgranular acute promyelocytic leukemia.
Bassan R; Battista R; Viero P; d'Emilio A; Buelli M; Montaldi A; Rambaldi A; Tremul L; Dini E; Barbui T
Leukemia; 1995 Feb; 9(2):238-43. PubMed ID: 7869758
[TBL] [Abstract][Full Text] [Related]
6. The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes.
Albano F; Mestice A; Pannunzio A; Lanza F; Martino B; Pastore D; Ferrara F; Carluccio P; Nobile F; Castoldi G; Liso V; Specchia G
Haematologica; 2006 Mar; 91(3):311-6. PubMed ID: 16531253
[TBL] [Abstract][Full Text] [Related]
7. Acute promyelocytic leukemia: morphological aspects.
Castoldi GL; Liso V; Specchia G; Tomasi P
Leukemia; 1994; 8 Suppl 2():S27-32. PubMed ID: 7815833
[TBL] [Abstract][Full Text] [Related]
8. Microgranular variant of acute promyelocytic leukemia in children.
Rovelli A; Biondi A; Cantù Rajnoldi A; Conter V; Giudici G; Jankovic M; Locasciulli A; Rizzari C; Romitti L; Rossi MR
J Clin Oncol; 1992 Sep; 10(9):1413-8. PubMed ID: 1517784
[TBL] [Abstract][Full Text] [Related]
9. Cytochemical stainings in acute promyelocytic leukemia: chloroacetate esterase reaction as a prognostic index.
Chinprasertsuk S; Piankijagum A; Issaragrisil S
J Med Assoc Thai; 1991 Feb; 74(2):87-91. PubMed ID: 1647435
[TBL] [Abstract][Full Text] [Related]
10. CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint.
Biondi A; Luciano A; Bassan R; Mininni D; Specchia G; Lanzi E; Castagna S; Cantù-Rajnoldi A; Liso V; Masera G
Leukemia; 1995 Sep; 9(9):1461-6. PubMed ID: 7658712
[TBL] [Abstract][Full Text] [Related]
11. Cytochemistry of acute promyelocytic leukemia (M3): leukemic promyelocytes exhibit heterogeneous patterns in cellular differentiation.
Tomonaga M; Yoshida Y; Tagawa M; Jinnai I; Kuriyama K; Amenomori T; Yoshioka A; Matsuo T; Nonaka H; Ichimaru M
Blood; 1985 Aug; 66(2):350-7. PubMed ID: 2410066
[TBL] [Abstract][Full Text] [Related]
12. Correlation between morphological and cytochemical heterogeneity of acute promyelocytic leukemia (APL) and its association with myelodysplasia.
Varma N; Dash S; Sarode R
Indian J Cancer; 1990 Sep; 27(3):165-71. PubMed ID: 2090569
[TBL] [Abstract][Full Text] [Related]
13. Cytochemical reactions in cells from leukemic dogs.
Grindem CB; Stevens JB; Perman V
Vet Pathol; 1986 Mar; 23(2):103-9. PubMed ID: 3962077
[TBL] [Abstract][Full Text] [Related]
14. Quantitative enzyme determination in acute myeloid leukemia.
Ossenkoppele GJ; Wijermans PJ; Huijgens PC; Nauta JJ; Langenhuijsen MM
Leuk Res; 1991; 15(6):481-6. PubMed ID: 1650411
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic and enzymatic studies do not support the concept of mixed monocytic-granulocytic differentiation in acute promyelocytic leukaemia (M3): a study of 44 cases.
Scott CS; Patel D; Drexler HG; Master PS; Limbert HJ; Roberts BE
Br J Haematol; 1989 Apr; 71(4):505-9. PubMed ID: 2653408
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis.
Lin P; Hao S; Medeiros LJ; Estey EH; Pierce SA; Wang X; Glassman AB; Bueso-Ramos C; Huh YO
Am J Clin Pathol; 2004 Mar; 121(3):402-7. PubMed ID: 15023045
[TBL] [Abstract][Full Text] [Related]
17. Leukemias resembling acute promyelocytic leukemia, microgranular variant.
Nagendra S; Meyerson H; Skallerud G; Rosenthal N
Am J Clin Pathol; 2002 Apr; 117(4):651-7. PubMed ID: 11939742
[TBL] [Abstract][Full Text] [Related]
18. Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors.
Avvisati G; Lo Coco F; Mandelli F
Semin Hematol; 2001 Jan; 38(1):4-12. PubMed ID: 11172535
[TBL] [Abstract][Full Text] [Related]
19. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes.
Paietta E; Goloubeva O; Neuberg D; Bennett JM; Gallagher R; Racevskis J; Dewald G; Wiernik PH; Tallman MS;
Cytometry B Clin Cytom; 2004 May; 59(1):1-9. PubMed ID: 15108165
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of acute promyelocytic leukemia: an experience in one institute emphasizing the morphological and immunophenotypic changes at the time of relapse.
Yoshii M; Ishida M; Yoshida T; Okuno H; Nakanishi R; Horinouchi A; Hodohara K; Okabe H
Int J Clin Exp Pathol; 2013; 6(10):2192-8. PubMed ID: 24133598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
